Delivery Order SPE2DB24D3013-SPE2DB25FFNMQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $3,977.47. This contract represents a firm fixed-price delivery order under a competitive, non-set-aside procurement and is scheduled for completion by July 25, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office and serves...
- The Defense Logistics Agency awarded a $25,044.82 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $4,013.94 to AmerisourceBergen Drug Corp for 90-count tablets of Myrbetriq ER 50 mg, a medication used to treat overactive bladder. Awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, this firm fixed-price contract utilized competitive procedures with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units) under a firm fixed-price contract valued at $8,276.16. The award was made on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,248.63 by the Defense Logistics Agency on July 25, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count packaging). The contract employs firm fixed pricing and carries an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate office and primary distribution hub...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $18,945.55. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025. This...
- The Defense Logistics Agency awarded a $7,089.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a non-set-aside contract performed at the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Myrbetriq ER 25 mg tablets (30-count units) with a ceiling value of $1,346.80. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by July 22, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,784.72 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside...
- The Defense Logistics Agency awarded a $8,004.31 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Myrbetriq ER 50 mg, a pharmaceutical product for urological treatment. The award, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFNMQDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,512.00 delivery order on July 21, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed-price contract with a completion date of July 22, 2025, and represents a non-set-aside competitive award. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a broad range of medications and medical supplies to support federal military and veteran healthcare systems. The SPE2DX IDC enables the company to deliver pharmaceuticals across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for Myrbetriq, a medication used to treat overactive bladder, exemplifies the routine pharmaceutical procurement activity conducted through the prime vendor contract, which facilitates flexible and efficient medical supply chain operations for the Department of Defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 7/21/25 |